日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review

利用代谢组学研究肠道菌群代谢谱与炎症性肠病患者精神障碍的关系:一篇叙述性综述

Zarei, Parvin; Sedeh, Peyman Adibi; Vaez, Ahmad; Keshteli, Ammar Hassanzadeh

Roadmap for a Systems Biology Initiative in Iran

伊朗系统生物学计划路线图

Kamali, Zoha; Jalilvandnejad, Amir; Falenji, Bentolhoda; Zarei, Parvin; Lotfi, Maryam; Hadizadeh, Fatemeh; Vaez, Ahmad

Investigating Causal Links between Metabolite Profiles and Ulcerative Colitis: A Bidirectional Mendelian Randomization Study

代谢物谱与溃疡性结肠炎因果关系研究:一项双向孟德尔随机化研究

Zarei, Parvin; Kamali, Zoha; Keshteli, Ammar Hassanzadeh; Sedeh, Peyman Adibi; Vaez, Ahmad

Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease.

胆红素是一种肝脏保护剂,它能激活 SIRT1、PGC-1α 和 PPAR-α,同时抑制代谢相关脂肪肝疾病大鼠的 NF-αB

Taghizadeh Motahareh, Maleki Mohammad Hasan, Vakili Omid, Tavakoli Ramin, Zarei Parvin, Dehghanian Amirreza, Bordbar Hossein, Shafiee Sayed Mohammad

The Application of Artificial Intelligence and Drug Repositioning for the Identification of Fibroblast Growth Factor Receptor Inhibitors: A Review

人工智能和药物重定位在成纤维细胞生长因子受体抑制剂鉴定中的应用:综述

Zarei, Parvin; Ghasemi, Fahimeh

Effects of coenzyme Q(10) supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial

辅酶Q10补充剂对2型糖尿病女性血清淀粉酶、腺苷脱氨酶、过氧化氢酶水平和总抗氧化能力的影响:一项随机、双盲、安慰剂对照试验

Zarei, Parvin; Rezvanfar, Mohammad Reza; Ansarihadipour, Hadi; Delavar, Mostafa; Abdollahi, Mahdi; Khosrowbeygi, Ali